Screening and management of dyslipidemia in oncologic patients undergoing cardiotoxic therapies: results from an Italian survey

Screening and management of dyslipidemia in oncologic patients undergoing cardiotoxic therapies: results from an Italian survey

Abstract Background Baseline cardiovascular risk factors correction is recommended in all cancer patients undergoing potentially cardiotoxic therapies. Despite available guidelines, real-world data on dyslipidemia prevalence and management in the oncologic population are still sparse. Methods This s...

Full description

Bibliographic Details
Main Authors: Massimiliano Camilli, Irma Bisceglia, Maria Laura Canale, Fabio Maria Turazza, Leonardo De Luca, Domenico Gabrielli, Michele Massimo Gulizia, Fabrizio Oliva, Furio Colivicchi
Format: Article
Language:English
Published: BMC 2023-08-01
Series:Cardio-Oncology
Subjects:
Dyslipidemia
cancer patients
National survey
Statins
Cardio-oncology
Online Access:https://doi.org/10.1186/s40959-023-00183-0

Internet

https://doi.org/10.1186/s40959-023-00183-0

Similar Items